Use of the subcutaneous route for the ad
โ
Eduardo Bruera; C. Brenneis; M. Michaud; R. Bacovsky; S. Chadwick; A. Emeno; N.
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 454 KB
๐ 2 views
From February 1985 until January 1987, 108 consecutive patients with pain due to advanced cancer requiring parenteral narcotics were treated with a subcutaneous infusion of morphine (62 patients) or hydromorphone (46 patients). Mean maximal daily dose of morphine and hydromorphone was 305 mg (range,